Differential (Click to cross reference) adverse drug reaction aggression agitation algorithm Alzheimer's disease Alzheimer's disease, behavioral symptoms Alzheimer's disease, treatment of anticholinesterase antidepressant anxiety atypical behavior behavior, combative behavioral disorder black box warning bromide carbamazepine caregiver cerebrovascular accident clozapine confusion confusional state, acute creatine phosphokinase(CPK)elevated dantrolene sodium delirium delirium, work up for delusion dementia dementia, treatment of depression dopamine agonist dopamine antagonist drug induced neurologic disorders efficacy encephalopathy epidemiology of neurology evidence-based research fever hallucination haloperidol hoarding inappropriate behavior L-dopa L-dopa, drug interactions with and side effects of lethargy memantine misdiagnosis mortality neuroleptic neuroleptic malignant syndrome neuroleptic, atypical neurologic disease, diagnoses of neurologic disease, diagnoses of, clinical bedside neurological intensive care nursing home olanzapine old age, neurology of paranoia Parkinson disease Parkinson disease, drug induced Parkinson disease, exacerbation postoperative neurologic complications prevention of neurologic disorders psychiatric problems in neurologic disorders psychomotor retardation psychosis psychotic behavior quality of life quetiapine repetitive questioning review article rigidity risk factors risperidone rummaging safety selective serotonin reuptake inhibitors shadowing sleep pathology and physiology stereotyped behavior treatment of neurologic disorder treatment, non-pharmacologic wandering

Showing articles 0 to 11 of 11 Assessment and Management of Behavioral and Psychological Symptoms of Dementia BMJ 350:h369, Kales, H.C.,et al, 2015 Delirium in Older Persons NEJM 354:1157-1165, Inouye,S.K., 2006 Atypical Antipsychotics in the Elderly with Parkinson Disease and the "Black Box" Warning Neurol 67:564-566, Friedman,J.H., 2006 Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006 Pharmacological treatment of Neuropsychiatric Symptoms of Dementia JAMA 293:596-608, Sink,K.M.,et al, 2005 Olanzapine and Clozapine Comparative Effects on Motor Function in Hallucinating PD Patients Neurol 55:789-794, 748, Goetz,C.F. et al, 2000 Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000 Olanzapine Can Worsen Parkinsonism Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998 Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease Neurol 50:1195-1196, Wolters,E.C.,et al, 1998 Olanzapine:A Novel Atypical Neuroleptic Agent Lancet 349:1264-1265, Reus,V.I., 1997 Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992 Showing articles 0 to 11 of 11